LSPN North America–Fall 2025

Meet some of this year’s incredible speaker lineup

➜ Register Your Interest

Amanda Simons

Partner

J A Kemp

BC Moore

Director, Global Intellectual Property

Illumina

Benjamin Pelletier

Partner

Haynes & Boone

Bethan Hopewell

Partner

Powell Gilbert

Brenda Hefti

Senior Vice President, Intellectual Property and Licensing, Legal Services

Exelixis

Caleb Bates

Head of IP (Legal)

Isomorphic Labs

Camille Terfve

Partner, Patent Attorney

Mewbern Ellis

Chuck Sholtz

Vice President, Intellectual Property

Nutcracker Therapeutics

David Gindler

Partner

Orrick

David Goetz

Senior Patent Attorney

Novartis

Dirk Buehler

Partner

Maiwald

Eldora Ellison

Director

Sterne Kessler

Joel Coles

Partner

Powell Gilbert

Mark Jackson

SVP, Intellectual Property

Editas Medicine

Martin Huenges

Partner

Maiwald

MaryAnne Armstrong

Partner

Birch, Stewart, Kolasch & Birch (BSKB)

Micheal Hebert

Shareholder

Greenberg Traurig

Nicole Williams

Senior Director, Intellectual Property & Litigation

10x Genomics

Rachel Elsby

Partner

Akin

Raymond Doss

Associate General Counsel, Intellectual Property & Litigation

Amgen

Reena Bajpai

Senior Counsel II

Gilead Sciences

Renee Fuller

Senior Corporate Counsel, Innovation Law

Bristol Myers Squibb

Rona Lamiquiz

Of Counsel

DLA Piper

Sanjesh Sharma

Assistant General Counsel-Patents

Johnson & Johnson

Susan Krumplitsch

Partner

DLA Piper

Tim Hott

Director, Intellectual Property

Guardant Health

➜ Register Your Interest

For speaking Opportunities Contact us today

LSPN North America—Fall is the premier event for IP professionals working in the life sciences industry.

150+ delegates will have a chance to hear from leading experts as they unpack the latest IP trends and best practices in the life sciences industry. The conference will cover a wide range of topics related to life sciences and patent law. soon as possible.

Day One includes an update on the US patent landscape and the European patent landscape, invention harvesting, priority pitfalls in the US and Europe, subject matter eligibility in the US, the CRISPR licensing landscape, PTAB reform, global portfolio management, trade secret protection, and patenting antibodies.

Day Two includes discussions on collaboration, diversity, and roundtable discussion groups on patent term adjustments, avoiding priority pitfalls, emerging trends in patent licensing and collaborations, and IP portfolio strategy. The conference focuses on best practices for maximizing innovation and managing IP portfolios.

Would you like to take part?

➜ Register Your Interest

Join us as as speaker at LSPN North America—Fall

Want to get involved?

Chair the conference
Make a stand-alone or joint presentation
Moderate a panel discussion
Participate in a panel discussion
Host a roundtable discussion group

LSPN North America—Fall will bring together a diverse group of attendees, including regulatory affairs professionals, pharmaceutical and biotechnology industry leaders, attorneys, policymakers, and compliance experts.

We are currently finalizing the agenda for the conference. If you would like to join the speaker faculty, please contact us as soon as possible.